PA
PRAX icon

Profund Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Profund Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Sell
6,097
-984
-14% -$311K 0.06% 195
2026
Q1 		$2.28M Sell
7,081
-1,374
-16% -$425K 0.08% 173
2025
Q4 		$2.49M Buy
8,455
+376
+5% +$70K 0.08% 166
2025
Q3 		$428K Buy
8,079
+2,818
+54% +$137K 0.01% 571
2025
Q2 		$221K Sell
5,261
-847
-14% -$32.3K 0.01% 845
2025
Q1 		$231K Sell
6,108
-451
-7% -$28.2K 0.01% 831
2024
Q4 		$505K Sell
6,559
-488
-7% -$35.3K 0.02% 512
2024
Q3 		$405K Sell
7,047
-639
-8% -$34.5K 0.02% 629
2024
Q2 		$318K Buy
+7,686
New +$363K 0.01% 692

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Profund Advisors's PRAX Position: Q2 2026 in Review

Profund Advisors reduced its Praxis Precision Medicines (PRAX) stake by 14% in Q2 2026, selling an estimated $311K and leaving 6,097 shares worth $2.04M. The position accounts for 0.06% of the portfolio, ranked #195.

Profund Advisors first reported a position in PRAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.49M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Profund Advisors held 6,097 shares of Praxis Precision Medicines worth $2.04M as of Q2 2026.
  • Profund Advisors sold 984 Praxis Precision Medicines shares in Q2 2026, an estimated $311K.
  • Praxis Precision Medicines made up 0.06% of Profund Advisors's portfolio in Q2 2026, its #195 holding.
  • Profund Advisors first reported a position in Praxis Precision Medicines in Q2 2024 and has held it in 9 quarters since.
  • Profund Advisors's Praxis Precision Medicines position peaked at $2.49M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.